Recent studies of ERs in breast cancer have demonstrated the existence of ERb in addition to ERa. Some clinical data indicated that ERb had prognostic value for patient's survival, which suggested that ERb plays a key role in breast cancer development and metastasis. To test this hypothesis, we generated an ERb high-expression cell line by reintroduced human ERb cDNA into MDA-MB-435 cells. We demonstrated that ERb exerted multiple tumor-stimulative effects on human breast carcinoma cells both in vivo and in vitro. In in vitro studies, ERb was able to increase the proliferation and invasion of MDA-MB-435 cells significantly, while these effects were totally estradiol independent. Also, this stimulation was characterized by downregulation of p21 and upregulation of MMP-9, as well as transcriptional factor Est-1. In in vivo studies, we also demonstrated that ERb-transfected MDA-MB-435 cells grew much faster and had more pulmonary metastasis than mock or wild-type cells in nude mice. In ERb-transfected MDA-MB-435 xenografts, ERb caused significant reduction in p21 protein levels. Similar effects of ERb on MMP-9 and Ets-1 expression noted in vitro studies were also observed in the in vivo studies. These in vitro and in vivo studies indicated that ERb exerted multiple stimulative effects on breast cancer development and metastasis.
Introduction
Breast cancer is the leading malignancy of woman in western countries. Estrogen is thought to be important in the pathogenesis of breast cancer. It is associated with most of the epidemiological risk factors such as age at menarche, age at first child, age at menopause, use of the oral contraceptive pill and use of hormone replacement therapy (Palmieri et al., 2002) . Estrogen acts on breast cells via the estrogen receptor (ER), which belongs to a large family of nuclear receptors. The ER is a transcription factor which, when bound to estradiol, binds DNA and regulates expression of estrogenresponsive genes (Beato et al., 1995) . Since the cloning of the ER in 1986, it was believed that a single receptor (now termed ERa) mediated the effects of estrogens on target tissues. Recently, a second ER, referred to as ERb, has been identified in the rat, human and mouse. Owing to the similar structural and functional composition with ERa, ERb was also shown to activate the transcription of target genes through similar estrogen response elements (Kuiper et al., 1996; Moore et al., 1998) . The discovery of ERb has prompted a reevaluation of the molecular bases for estrogen action. ERb expressed in human breast cancer (Dotslaw et al., 1997) and the ratios of ERa : ERb gene expression altering during carcinogenesis suggested that ERa and ERb drive pathways and/or their interaction change during this process (Leygue et al., 1998) . ERa and ERb mRNA coexpression assayed by reverse transcription PCR might act as a poor prognostic factor in human breast cancer patients (Dotslaw et al., 1999) . In a previous study, we had shown that ERb had prognostic value for both relapse-free survival and overall survival (Po0.05) in human breast cancer patients (Wen et al., 2002) . All these data suggested that ERb plays a key role in breast cancer development and metastasis. To further test this hypothesis, we have generated an ERb highexpression cell line from both ERa-and ERb-negative breast cancer cells. We demonstrated that ERb exerted multiple tumor-stimulative effects on human breast carcinoma cells both in vivo and in vitro. These stimulative effects include not only growth stimulation, but invasion as well. The mechanisms of these multiple stimulative effects include either the upregulation or the downregulation of different effector molecules.
Results

Stable transfection of ERb cDNA in ERaand ERb-negative MDA-MB-435 cells
To study ERb expression in human breast cancer, we performed RT-PCR and Western blot analyses on MDA-MB-435 cells. As shown in Figure 1 , we found that MDA-MB-435 cells were truly ERb-negative cells.
MDA-MB-435 cells were stably transfected with expression vectors carrying human ERb cDNA. Several puromycin-resistant clones were tested for the integration of the ERb expression vector into the transfectants, as shown in Figure 1a , b. Two ERb transfectants (ERb1 and ERb2) expressed both ERb mRNA and protein. In this study, both clones were used to make in vitro experiments.
To further assess the functionality of the receptors produced, we analysed their ability to transactivate estrogen-regulated reporter genes, such as TGFa. ERb was able to activate the expression of TGFa mRNA in an estradiol-dependent manner (Figure 2 ).
ERb enhancement of proliferation and modulation of relevant effector molecules in in vitro studies
To investigate whether ERb expression could modulate the proliferation rate of MDA-MB-435 cells, we assessed the growth rate of ERb-and mock-transfected cells. As shown in Figure 3 , ERb was able to increase the proliferation of MDA-MB-435 cells significantly, while this effect was totally estradiol independent. The results of flow cytometry analysis also showed that the percentage of S phase in cells expressing ERb (46.77%) was significantly higher than the mock-transfected (29.98%) or wild-type (27.59%) cells (Po0.05).
By RT-PCR, ERb-transfected MDA-MB-435 cells constitutively expressed 30% lower levels of p21 WAF1/CIP1 mRNA and 50% lower in p21 WAF1/CIP1 protein than mock-transfected or wild-type cells (Po0.05) (Figure 4a, b and Figure 5a, b) , whereas we did not find any significant difference in cyclin D1, cyclin A, cyclin E and c-myc mRNA expression among ERb-transfected MDA-MB-435 cells, mock-transfected and wild-type cells (data not shown).
ERb enhancement of invasion and modulation of relevant effector molecules in in vitro studies
It was of interest to investigate whether ERb expression might affect the ability of cell motility. To address this issue, we performed invasion study using the classic Transwell in vitro assay. ERb-transfected MDA-MB-435 cells resulted in a significant increscent of invasion (50% enhancement of invasion occurred) in an estradiol-independent manner when compared to mocktransfected and wild-type cells (data not shown). To further study the potential mechanisms of ERb enhancement of invasion, we examined the MMP expression both in mRNA and protein levels. By RT-PCR, ERb-transfected MDA-MB-435 cells constitutively expressed high levels of MMP-9 mRNA, 2.1-fold higher compared to mock-transfected and wild-type cells (Figure 4a, b) . By direct gelatin zymography, ERbtransfected MDA-MB-435 cells constitutively secreted high levels of MMP-9, 1.8-fold higher compared to mock-transfected and wild-type cells (Figure 6a, b) . However, we did not find any significant difference in MMP-1, MMP-2, MMP-7 mRNA expression among ERb-transfected MDA-MB-435 cells, mock-transfected and wild-type cells (data not shown). As the effects of ERb were pronounced on MMP-9, we decided to further examine the expression of transcriptional factor Ets-1. As shown in Figure 4a , b and Figure 5a , b, ERbtransfected MDA-MB-435 cells constitutively expressed higher levels of Ets-1 both in mRNA and protein levels, when compared to mock-transfected and wild-type cells (Po0.05).
The results of in vitro studies also indicated that there was no significant difference between these ERb expression clones in proliferation or invasion effects (Figures 2-6 ).
ERb enhancement of tumor growth, tumor metastasis and modulation of relevant effector molecules in in vivo studies
ERb-transfected MDA-MB-435 cells (ERb1 group) grew much faster than mock-transfected or wild-type cells in nude mice (Figure 7 ) (Po0.05). When studying the pulmonary metastasis, it was clearly shown that there was almost two-fold increase of lung metastasis in the ERb1 group compared to that in the mocktransfected or wild-type group (Figure 8d ) (Po0.01). In xenografts of the ERb1 group, ERb caused significant reduction in p21 protein levels (Figure 9a, b) . Similar effects of ERb on MMP-9 and Ets-1 expression noted in the in vitro studies were also observed in the in vivo studies (Figure 9a , b). However, ERb did not modulate serum angiogenesis factors such as VEGF and b-FGF levels in xenografts (data not shown). The experiment results from male nude mice also confirmed the former conclusions (data not shown). The other clone, ERb2, was also used during the above studies; there was no significant difference between these two clones (data not shown).
Discussion
This study provides evidence that ERb exerts multiple different stimulative effects on human breast carcinoma cells both in vitro and in vivo. The in vitro stimulative actions of ERb were not limited to proliferation. ERb exerted strong stimulation of invasive effects in vitro that, like its stimulation of proliferative effects, were independent of estradiol.
Recent studies of ERs in breast cancer have demonstrated the existence of ERb in addition to ERa. Both ER subtypes have eight exons which encode six functional domains, designated A-F, which are highly Mosselman et al., 1996; Enmark et al., 1997; Ogawa et al., 1998) . Thus, these two independent receptors may play some different roles in breast cancer.
Many functions have been suggested for ERb in breast cancer, but still no clear picture has emerged about its role in breast cancer. Hu et al. (1998) reported that ERb contributed to the initiation and progression of chemical carcinogen-induced neoplastic transformation in breast. Leygue et al. (1997) showed that those tumors co-expressing ERa and ERb were node-positive and tended to be of higher grade. However, Jarvinen et al. (2000) found that ERb was often co-expressed with ERa and progesterone receptor in breast cancer and that ERb was significantly associated with negative axillary node status and low tumor grade. All of these controversial results make it necessary to establish a breast cancer model, which only expresses ERb to study its real function. In present study, we reintroduced the ERb gene into human breast cancer MDA-MB-435 cells which do not express endogenous both ERa and ERb proteins. Our results demonstrated that ERb was able to increase the proliferation of MDA-MB-435 cells significantly, while this effect was totally estradiol independent. This increase in proliferation was accompanied by downregulation of p21 both in mRNA and protein levels. The cell proliferation is regulated by CdKs in association with different cyclins (Haggitt, 1994; Delsal et al., 1996; Sherr, 1996) . Different CdK-cyclin complexes are required at various stages of cell cycle. Cyclin-CdK activity is regulated by phosphorylation events and cyclin kinase inhibitors, which bind the cyclin-Cdk complexes and inhibit their activity. The P21 WAF/CIP1 family is an important group of CKis, including the p21, p27 and p57 proteins, which share partial structural homology and posses the ability to inhibit several cyclin-CdK complexes. Our results showed that the downregulation of p21 might be one of the possible mechanisms of proliferation enhancement by ERb.
Our results demonstrated that ERb enhanced the migration and invasion of MDA-MB-435 cells in an estrogen-independent manner in in vitro study. In in vivo study, we also demonstrated that ERb-transfected MDA-MB-435 cells grew much faster than mocktransfected or wild-type cells in nude mice. If comparing the pulmonary metastasis, it was clearly shown that there was almost two-fold increase of lung metastasis in ERb-transfected MDA-MB-435 xenografts when compared to that in mock-transfected or wild-type cells. All these were related to upregulation of MMP-9 and Ets-1 levels. MMPs are important group of zinc enzymes that are responsible for degradation of extracellular matrix components such as collagen and proteoglycans in normal embryogenesis and in many disease processes such as arthritis and invasion by carcinoma (Iurlaro et al., 1999; Sillem et al., 1999) . In the endometrium, it has been reported that some MMPs play important roles in endometrial physiologic characteristics and these roles are regulated by ovarian steroid hormones (Irwin et al., 1996) . Mizumoto et al. (2002) reported that the expression of MMP-1, -7 and -9 was enhanced in Ishikawa cells with ERa positive in the E2-containing condition according to the acceleration of their invasiveness. In our system, we also demonstrated that the enhancement of invasion by ERb was accompanied by upregulation of MMP-9.
Recent studies have revealed that Ets-1, which is one of the Ets family members, activates promoters of different subclasses of the MMP genes (Higashino et al., 1995) . Some investigators reported that the high expression of Ets-1 was correlated with tumor progression and bad prognosis (Saeki et al., 2000; Nakayama et al., 2001) . Our data showed that the expression of Ets-1 was accelerated by ERb and exhibited a tendency similar to MMP-9. These suggested that the upregulation of MMP-9 be stimulated by ERb via activation of Ets-1 expression.
Angiogenesis is essential for the growth and metastasis of solid tumors (Folkman, 1990) . Among the many reported angiogenic factors, VEGF and b-FGF are the most powerful endothelial-cell-specific mitogens associated with tumor neovascularization. However, these two important angiogenic factors may not play a role in ERb-transfected cells which have more lung metastasis. Tonetti et al. (2003) findings as ours and they reported that with Erb protein expression increasing the cell proliferation rate accelerated (Tonetti et al., 2003 However, all of these studies showed that the effects of ERb on tumor cells were all estradiol-independent, which suggested that there exist some new pathways to activate ERb.
In conclusion, this study provides evidence that ERb exerts multiple different stimulative effects on human breast cancer cells both in vitro and in vivo. The stimulative actions of ERb are not only involved in proliferation, but also in invasion. These stimulative effects were independent of estrogen.
Materials and methods
Regents and cell lines
Dulbecco's modified Eagle's medium, Ham's F-12 medium (DMEM/F12), and fetal bovine serum (FBS) were obtained from Life Technologies, Inc. Iscove's modified Eagle's medium (phenol red free) were purchased from Biofluids (Rockville, MD, USA). Dextran-charcoal and sulfatase-treated FBS (CSS) were obtained from GiBCO/BRL (Grand Island, NY, USA). Puromycin and 17b-estradiol were obtained from Sigma (St Louis, MO, USA). The plasmid PSG5 containing human ERb cDNA was kindly provided by Dr P Chambon (IGBMC, Strasbourg, France). Compared with the published sequences of human ERb, the type of ERb plasmid which was used in our study is similar to Dr Ogawa's (Ogawa et al., 1998) .
Human breast cancer cell line MDA-MB-435 was obtained from ATCC. Cells were routinely cultured in DMEM/F12 medium supplemented with 10% FBS. CSS was prepared essentially as mentioned previously . The cultures were incubated at 371C in a humidified 5% CO 2 atmosphere.
Stable transfections
For stable transfection of ERb cDNA, the MDA-MB-435 cells were initially plated at a density of 3 Â l0 5 cells in a six-well plate 24 h before transfection in regular medium. In all, 2 mg of the expression plasmid PSG5 with or without hERb cDNA was transfected using the Lipofectin (Life Technologies, Inc., Rockville, MD, USA). After 48 h, the medium was replaced and puromycin (2 mg/ml) was added to select stable transfectants. Puromycin-resistant colonies were selected in medium with puromycin (2 mg/ml) and expanded. The ERb-positive colonies were identified by RT-PCR and Western blot. In this study, the clone in which Erb gene was successfully transfected was named MDA-MB-435/Erb (two positive clones were selected, named ERb1 and ERb2, respectively.). The one only transfected with puromycin-resistant gene was named MDA-MB-435/PSG5 (PSG5).
Expression analysis of hERb transfectants
RNA isolation and RT-PCR analysis Total RNA was isolated from cells using Trizol reagent (Life Technologies, Inc), according to the manufacturer's recommendations. In all, 1 mg of total RNA was converted to cDNA using an avian myeloblastosis virus reverse transcription system (Promega, Madison, WI, USA). A measure of 2.5 ml out of each RT reaction mixture was applied to 25 ml of PCR mixture, containing 2.5 U AmpliTaq DNA polymerase (Promega), 1.5 mmol/l MgCl 2 , 1 Â Taq buffer and 0.2 mmol/l 4 deoxynucleotide triphosphates (dNTPs). The specific primers of ERb used in the experiment were ERb up 5 0 -TGCTTTGGTTTGGGTGATTGC-3 0 and ERb down 5 0 -TTTGCTTTTACTGTCCTCTGC-3 0 259 bp. In total, 30 cycles of PCR were carried out with the program of 45 s at 941C, 30 s at 581C and 1 min at 721C. Part of the PCR products was electrophoresed on 1.5% agarose gel and imaged on an Alpha Image 950 documentation system (Alpha Innotech, San Leandro, CA, USA). Densitometry of images was performed using NIH Image version 1.62. Testis tissues were used as positive control of ERb. Total mRNA samples without reverse transcription were used as negative control.
Western blot
Cells were washed twice with ice-cold PBS and scarped into 1 ml of ice-cold NP40 lysis buffer (10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% (v/v) NP40, 1 mM EDTA, 50 mM NaF, 5 mM Na PPI ,1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin and 1 mg/ml pepstatin A). Cells were then sonicated for 5 s at 5 W. Insoluble debris was removed by centrifugation at 1000 g for 15 min. Total proteins (50 mg) were analysed by 10% SDS-PAGE. Western blot, using polyclonal antibodies to ERb (Oncogene Research Products, Cambridge, MA, USA), was performed according to standard protocols (Shao et al., 1998) . Testis tissues were used as positive control of ERb. Blot quantitation was done with a Molecular Dynamics Laser Densitometer (Model PSD) and the Image Quant Version 1 software.
Growth experiments
For growth experiments, cells were plated at 5000 cells/well in 96-well plates in DMEM/F12 medium supplemented with 5% fetal bovine serum overnight. The cells were washed three times with phenol red-free DMEM with 10% CSS. After the third wash, the cells were incubated with phenol red-free DMEM with 10% CSS containing various concentrations of 17b-estradiol. The cells were harvested after 72 h and assessed by standard MTT methods (van Golen et al., 1996) .
Analysis of cell cycle phase distribution
Flow cytometry analysis of DNA content was performed to assess the cell cycle phase distribution as described previously (Shao et al., 1998) . ERb, mock-transfected and wild MDA-MB-435 cells were harvested and stained for DNA content using propidium iodide fluorescence. The computer program Multicycle from Phenix Flow System (San Diego, CA, USA) was used to generate histograms, which were used to determine the cell cycle phase distribution.
In vitro assays of invasion
Invasion experiments were conducted with a Matrigel invasion chamber (BD Labware, Bedford, MA, USA) (Albini, 1998) . Each well insert was layered with 120 ml of 1 : 3 mixture Matrigel : MEM (1400 mg Matrigel/cm 2 ) with or without various concentrations of estradiol. An amount of 10 5 cells were added to the top of this Matrigel layer. The wells were incubated at 371C for 36 h. Invasion was assessed by counting the cells that had traveled across the filter and were attached to the bottom side of the filter. Then, the filters were fixed in 10% formalin and stained with H&E. Cells which had invaded through the Matrigel and reached the lower surface of the filter were counted under a light microscope at a magnification of Â 200. Five fields should be counted for each sample.
RT-PCR for TGFa MMPs, cyclin D1, cyclin A, cyclin E, P21, Ets-1, VEGF and b-FGF We had described the procedure above. Here we just listed specific primers and their annealing temperatures (Table 1) .
Western blot for P21 and Ets-1
The method of Western blot had been described previously. In all, 15 and 10% polyacrylamide gels were used to detect P21 and Ets-1 proteins, respectively. The blots were probed with primary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1 : 500, and then incubated with a horseradishperoxidase anti-rabbit antibody (Amersham Pharmacia Biotech) diluted 1 : 2000. Normalization of protein loading was done with b-actin.
Gelatin zymography
For gelatin zymography, cell cultures were maintained to 80% confluency in 10% CCS DMEM/F12. Then cells were incubated under serum-free conditions for 24 h. At the time of medium collection, the cells were counted for the purpose of adjusting the volume of the medium to the cell number. MMP9 activity was assessed using 10% zymogram gels (Bio-Rad, Richmond, CA, USA). After electrophoresis, gels were rinsed in 2.5% Triton X-100 for 30 min and then enzyme degradation was performed at 371C for 40 h in 100 mmol/l Tris (pH 7.5), 5 mmol/l CaCl 2 and 0.04% NaN 3. The gels were stained with 2.5% Coomassie Blue and air-dried. Densitometry was used to analyse relative MMP9 activity with NIH Image version 1.62.
In vivo study with animal experiment
Female and male athymic BALB/c nu/nu mice, 4-6-week old, were obtained from the Shanghai Institute of Material Medica, Chinese Academy of Science, and housed in laminar-flow cabinets under specific pathogen-free (SPF) condition. All studies on mice were conducted in accordance with the National Institutes of Health 'Guide for the Care and Use of Laboratory Animals'. The study protocol was approved by the Shanghai Medical Experimental Animal Care Committee.
The tumorigenicity and spontaneous metastatic capability of the cell lines were determined by injection into the mammary fat pad (MFP). In total, 1 Â 10 6 cells in 0.1 ml of culture medium were inoculated into the anesthetized mouse. Animals were divided into three groups (MDA-MB-435, MDA-MB-435/PSG5 and MDA-MB-435/Erb group). Each group had six mice. Animals were monitored every 2 days for up to 8 weeks for tumor growth and general health. The rate of primary tumor growth of different cells was determined by plotting the means of two orthogonal diameters of the tumors, measured at 7-day intervals. Animals were killed and autopsied at 8 weeks post-inoculation. The lungs that were used to evaluate the numbers of metastasis were fixed in Bouin's liquid for 24 h at first. Then they were stored in 100% ethanol. When the lungs restored their inherent color, the metastasis deposits with white color could be assessed by macroscopic observation. To confirm the presence of lung metastases, sections were cut at 50 mm intervals and H&E staining were performed. In this study, we count metastasis in whole lung. Two independent pathologists calculated the numbers of metastasis. Tissue samples harvested for histological analysis were either fixed and embedded in paraffin wax or snap-frozen in liquid nitrogen (Urquidi et al., 2002) .
Statistical analysis
Analysis of variance and Student's t-test were used to determine the statistical significance of differences among experimental groups.
